Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study

World Journal of Urology

Volumn 35, Issue 9, 2017, Pages 1435-1442

  Siemens, D Robert ^a   Jaeger, Melanie T ^a   Wei, Xuejiao ^b   Vera Badillo, Francisco ^a   Booth, Christopher M ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Bladder cancer; Health services; Outcomes; Quality of care; Survival; Transfusion

Indexed keywords

ADULT; AGE; AGED; ALLOTRANSPLANTATION; ANEMIA; BLADDER TUMOR; BLOOD TRANSFUSION; CANCER STAGING; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CYSTECTOMY; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PERIOPERATIVE PERIOD; PLASMA; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX FACTOR; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; TRANSITIONAL CELL CARCINOMA; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD TRANSFUSION; CARCINOMA, TRANSITIONAL CELL; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CYSTECTOMY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PATIENT READMISSION; PERIOPERATIVE CARE; PLASMA; PLATELET TRANSFUSION; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 85013082486     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-017-2009-5     Document Type: Article

References (31)

1. Leveridge MJ, Siemens DR, Mackillop WJ et al (2015) Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study. Urology 85(4):791–798
2. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 1 19(3):666–675
3. Gandaglia G, Varda B, Sood A et al (2014) Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database. Can Urol Assoc J 8(9–10):E681–E687
4. Siemens DR, Mackillop WJ, Peng Y et al (2014) Processes of care and the impact of surgical volumes on cancer-specific survival: a population-based study in bladder cancer. Urology 84(5):1049–1057
5. Hallet J, Tsang M, Cheng ESW et al (2015) The impact of perioperative red blood cell transfusions on long-term outcomes after hepatectomy for colorectal liver metastases. Ann Surg Oncol 22:4038–4045
6. Murphy GJ, Barnaby C, Reeves BC et al (2007) Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116:2544–2552
7. Chander AS, Goodnough LT (2010) Blood transfusion as a quality indicator in cardiac surgery. JAMA 304:1610–1611
8. Dixon E, Datta I, Sutherland FR et al (2009) Blood loss in surgical oncology: neglected quality indicator? J Surg Oncol 99:508–512
9. Hill GE, Frawley WH, Griffith KE et al (2003) Allogenic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 54:908–914
10. Agarwal N, Murphy JG, Cayten CG et al (1993) Blood transfusion increases the risk of infection after trauma. Arch Surg 128:171–177
11. Ball CG, Pitt HA, Kilbane ME et al (2010) Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB†¯ Off J Int Hepato Pancreato Biliary Assoc 12(7):465–471
12. McAlister FA, Clark HD, Wells PS et al (2001) Perioperative allogenic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 85:171–178
13. Busch OR, Hop WC, Marquet RL et al (1994) Blood transfusions and local tumor recurrence in colorectal cancer: evidence of a noncausal relationship. Ann Surg 220:791–797
14. Crowe JP, Gordon NH, Fry DE et al (1989) Breast cancer survival and perioperative blood transfusion. Surgery 106:836–841
15. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 25;(1):CD 005033, 2006.
16. Albisinni S, Oderda M, Fossion L et al (2016) The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology. World J Urol 34:149–156
17. Ng CK, Kauffman EC, Lee M-M et al (2010) A comparison of postoperative complications in open versus robotic cystectomy. Eur Urol 57:274–282
18. Sadeghi N, Badalato GM, Hruby G et al (2012) The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma. Can J Urol 19(5):6443–6449
19. Linder BJ, Frank I, Cheville JC et al (2013) The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 63(5):839–845
20. Abel JE, Linder BL, Bauman TM et al (2014) Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol 66(6):1139–1147
21. Moschini M, Dell’ Oglio P, Capogrosso P et al (2015) Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: results from a single high-volume institution. Clin Genitourin Cancer 13(6):562–567
22. Kluth LA, Xylinas E, Rieken M et al (2014) Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. BJU Int 113(3):393–398
23. Jahnson S, Bergström R, Pedersen J (1994) Extent of blood transfusion and cancer-related mortality after cystectomy and urinary diversion for bladder cancer. Br J Urol 74(6):779–784
24. Clarke EA, Marrett LD, Krieger N (1991) Cancer registration in Ontario: A computer approach. In: Jenson OM, Parkin DM, MacLennan R (eds) Cancer registration principles and methods. IARC, Lyon, pp 246–257
25. Williams J, Young W (1996) A summary of studies on the quality of health care administrative databases in Canada. In: Goel V, Williams JI, Anderson GM et al (eds) Patterns of health care in Ontario: The ICES Practice Atlas, 339–345. Canadian Medical Association, Ottawa
26. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619
27. Hopewell S, Omar O, Hyde C et al (2013) A systematic review of the effect of red blood cell transfusion on mortality: evidence from large-scale observational studies published between 2006 and 2010. BMJ Open 3:e002154. doi:10.1136/bmjopen-2012-002154
28. Vamvakas EC (2011) Establishing causation in transfusion medicine and related tribulations. Transfus Med Rev 25:81–88
29. Liu L, Wang Z, Jiang S et al (2013) Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PloS one 8(5):e64261
30. Wang Y-L, Jiang B, Yin F-F et al (2015) perioperative blood transfusion promotes worse outcomes of bladder cancer after radical cystectomy: a systematic review and meta-analysis. PLoS One 10(6):e0130122
31. Ferraris VA, Davenport DL, Saha SP et al (2012) Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 147(1):49–55